News & Insight

20 October 2021
News
New findings, old ideas: reviving a decades old view on the causes of cancer
Mutographs
Surprising discoveries from the Mutographs team challenge the classical view that all carcinogens directly cause mutations and suggest that non-mutagenic agents play a greater role in tumour promotion than originally thought. This story…

Latest

News
20 October 2021
Today we launch Discover: a year of scientific creativity – our annual progress magazine showcasing the power of global team science.  Discover …
News
20 October 2021
The SPECIFICANCER team delves deeper into the biological laws that govern tissue specificity in cancer and reveals intricate webs of genetic…
News
20 October 2021
A new expansion sequencing toolbox and analysis platform from the IMAXT team reveals hidden truths in biology by creating detailed nanoscale-…
News
20 October 2021
A deeper understanding of the metabolic changes during tumour development could radically change clinical decision-making and unlock opportunities to…

Latest tweet

Our keynote speaker @UriAlonWeizmann spoke (and sang) about how a career in research is not always as glamourous an… https://t.co/JpblYOWvTO Thu Oct 14 15:21:40 +0000 2021

News and insight archive

Format
Choose
Team
Choose
Tags
Choose
News
In a new Science paper, members of the Cancer Grand Challenges IMAXT team announce ExSeq – new technology that can create nanoscale-resolution genomic maps of tumour samples by combining the expansion of biological…
29 January 2021
Blog
In October, Cancer Grand Challenges posed 9 new quests for the research community, each with the potential to contribute major advances to the way we think about and deal with the burden of cancer. Through our new blog…
25 January 2021
Blog
In October, we posed 9 new challenges to the research community, each with the potential to change the way we think about cancer. Through our new blog series, members of our Cancer Grand Challenges Scientific Committee …
19 January 2021
Video
In October 2020 we launched 9 new challenges to the global research community, each with the potential to drive radical progress in cancer research. Solving these problems will demand tenacity, creativity and worldwide…
19 January 2021
People
New findings from the Rosetta team have identified the antiporter SLC7A5 as a target for KRAS-driven colorectal cancer. We spoke with some of the co-authors to get their take on how a multidisciplinary team approach…
7 January 2021
Blog
In October, we posed 9 new challenges to the research community, each with the potential to change the way we think about cancer. Through our new blog series, members of our Cancer Grand Challenges Scientific Committee …
6 January 2021
News
Congratulations to STORMing Cancer’s Professor Don Ingber for winning Yale University’s Wilbur Cross Medal for Alumni Achievement.   Don pioneered the field of mechanobiology when he first made the link between the…
17 December 2020
Blog
In October, we posed 9 new challenges to the research community, each with the potential to change the way we think about cancer. Through our new blog series, members of our Cancer Grand Challenges Scientific Committee …
14 December 2020
Coverage
In a commentary article for AACR Cancer Discovery In Focus, Dr Iain Foulkes and Dr Ned Sharpless discuss the 9 Cancer Grand Challenges open for application from now until 22 April 2021. “Making progress in these fields…
8 December 2020